Topical propranolol improves epistaxis in patients with hereditary hemorrhagic telangiectasia - a preliminary report
Abstract Background Severe epistaxis is often difficult to control in patients with hereditary hemorrhagic telangiectasia (HHT). Propranolol has been shown to have antiangiogenic properties in vitro and in vivo and is commonly used to treat hemangiomas. We present our experience with topical nasal p...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
SAGE Publishing
2017-10-01
|
| Seri Bilgileri: | Journal of Otolaryngology - Head and Neck Surgery |
| Konular: | |
| Online Erişim: | http://link.springer.com/article/10.1186/s40463-017-0235-x |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|